Table 2A:
Cox Multivariable Model for relapse, non-relapse mortality (NRM) and overall survival (OS) by immunophenotype (P< 0.01 is indicated in bold). DC=dendritic cell
Cell type | Relapse | NRM | Overall Survival | ||||||
---|---|---|---|---|---|---|---|---|---|
HR | 95% Cl | P-value | HR | 95% Cl | p-value | HR | 95% Cl | p-value | |
CD3+ | 0.73 | 0.56, 0.97 | 0.03 | 0.56 | 0.40, 0.80 | 0.0015 | 0.55 | 0.44, 0.69 | <0.0001 |
CD3+CD4+ | 0.76 | 0.57, 1.02 | 0.06 | 0.46 | 0.34, 0.64 | <0.0001 | 0.49 | 0.40, 0.62 | <0.0001 |
CD3+CD8+ | 0.79 | 0.63, 0.99 | 0.04 | 0.72 | 0.53, 0.98 | 0.03 | 0.66 | 0.55, 0.80 | <0.0001 |
CD3+CD4+CD25+ | 0.89 | 0.69, 1.13 | 0.33 | 0.68 | 0.55, 0.84 | 0.0004 | 0.67 | 0.57, 0.78 | <0.0001 |
Tcon | 0.82 | 0.65 1.04 | 0.10 | 0.55 | 0.41 0.72 | <0.0001 | 0.57 | 0.47 0.69 | <0.0001 |
Treg:Tcon | 1.13 | 0.69, 1.84 | 0.63 | 1.38 | 0.76, 2.51 | 0.29 | 1.54 | 1.03, 2.28 | 0.03 |
Treg:CD8 | 1.29 | 0.72, 2.32 | 0.39 | 0.80 | 0.35, 1.82 | 0.60 | 1.12 | 0.66, 1.91 | 0.68 |
CD19+ | 1.27 | 1.05, 1.53 | 0.0144 | 0.71 | 0.58, 0.86 | 0.0006 | 0.74 | 0.65, 0.84 | <0.0001 |
CD3−CD56+ | 0.73 | 0.56, 0.96 | 0.02 | 0.65 | 0.46, 0.91 | 0.012 | 0.66 | 0.53, 0.81 | 0.0001 |
Total WBC | 0.56 | 0.39, 0.82 | 0.0029 | 1.79 | 0.93, 3.47 | 0.08 | 0.81 | 0.56, 1.18 | 0.28 |
ALC | 0.83 | 0.57, 1.20 | 0.33 | 0.64 | 0.38, 1.07 | 0.09 | 0.57 | 0.42, 0.76 | 0.0001 |
cDC (Lin−/HLADR+/CD123−/CDllc+) | 0.991 | 0.875 1.123 | 0.89 | 0.995 | 0.838 1.182 | 0.96 | 1.012 | 0.903 1.134 | 0.833 |
pDC (Lin−/HLADR+/CD123+/CDllc−) | 1.192 | 1.008 1.41 | 0.039 | 0.808 | 0.683 0.956 | 0.013 | 1.016 | 0.902 1.146 | 0.79 |